SCHEMBL7355446

SCHEMBL7355446

COc1c[c]ccc1C(C)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.46
LMNA P02545 5/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
ALDH1A1 P00352 4/20 0.42
KDM4E B2RXH2 2/20 0.42
HSD17B10 Q99714 1/20 0.42
CYP3A4 P08684 2/20 0.41
MAPT P10636 3/20 0.40
GAA P10253 1/20 0.40
CA9 Q16790 2/20 0.39
HPGD P15428 2/20 0.39
MAPK1 P28482 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
PDE4A P27815 1/20 0.37
RAB9A P51151 2/20 0.36
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA7 P43166 1/20 0.35
CA14 Q9ULX7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL182820 0.86 ALDH1A1 (0.49) HTTALDH1A1KDM4EHSD17B10MAPT
SCHEMBL8317114 0.86 HTT (0.44) HTTLMNASMN1; SMN2ALDH1A1KDM4E
SCHEMBL182737 0.85 KDM4E (0.44) HTTLMNAALDH1A1KDM4EHSD17B10
SCHEMBL182690 0.85 MKNK1 (0.40) HTTLMNAALDH1A1KDM4ECYP3A4
SCHEMBL182862 0.82 PLK1 (0.49) SMN1; SMN2ALDH1A1HSD17B10MAPTGAA
SCHEMBL182598 0.82 SMN1; SMN2 (0.35) SMN1; SMN2ALDH1A1CYP3A4MAPTGAA
SCHEMBL9827992 0.79 TSHR (0.49) LMNASMN1; SMN2ALDH1A1HSD17B10CYP3A4
SCHEMBL2092525 0.79 ALDH1A1 (0.35) LMNASMN1; SMN2ALDH1A1KDM4ECYP3A4
SCHEMBL1205065 0.77 TNFSF11 (0.46) SMN1; SMN2ALDH1A1KDM4EHSD17B10CYP3A4
SCHEMBL1325901 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1206219-C N-ureidoalkyl-piperidines as modulators of chemokine receptor activity BRISTOL MYERS SQUIBB CO (US) 2005-06-15 CN disclosed
US-6274383-B1 REACTING AN AMINO BOUND TO A SOLID SUPPORT WITH AN ISATOIC ANHYDRIDE TO FORM A 2-AMINOBENZAMIDE BOUND TO THE SUPPORT, AND THEN REACTING WITH ALDEHYDE USING A LEWIS ACID CATALYST TO FORM A 2,3-DIHYDRO-4(1H)-QUINAZOLINONE BOUND TO SUPPORT SEPRACOR INC. 2001-08-14 US disclosed
CN-1227555-A Cytokine production inhibitors triazepine compounds, and intermediates thereof JAPAN TOBACCO INC (JP) 1999-09-01 CN disclosed
CN-1171788-A Therapeutic agent for osteoporosis and triaza * compound JAPAN TOBACCO INC (JP) 1998-01-28 CN disclosed
US-5652247-A VASOPRESSIN ANTAGONIST OTSUKA PHARMACEUTICAL CO., LTD (JP) 1997-07-29 US disclosed
US-5436254-A Vaopressin antagonists OTSUKA PHARMACEUTICAL COMPANY, LTD. (JP) 1995-07-25 US disclosed
EP-0602209-A1 OXYTOCIN ANTAGONIST OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1994-06-22 EP disclosed
EP-0382185-B1 Carbostyril derivatives OTSUKA PHARMA CO LTD (JP) 1994-06-15 EP disclosed
WO-1994001113-A1 OXYTOCIN ANTAGONIST OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1994-01-20 WO disclosed
US-5225402-A Vasopressin antagonist, vasodilation, hypotensive, diuretics and anticoagulants OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1993-07-06 US disclosed